ABSTRACT
Background Focal and rotational activations have been demonstrated in AF, but their relationship to each other and to structural remodeling remains unclear.
Methods Patients undergoing catheter ablation for persistent AF were included. All patients underwent pulmonary vein isolation. Unipolar signals were collected to identify focal and rotational drivers using a wavefront propagation algorithm. Aim was to assess the relationship of drivers to underlying low voltage zones (LVZs; <0.5mV) and to determine whether there was a temporal (≤500ms) and spatial (≤12mm) relationship between focal and rotational drivers.
Results In 40 patients, 86 drivers were identified (57, 66.3% focal and 29, 33.7% rotational). Rotational drivers showed co-localized to LVZs (21/29, 72.4%) whilst focal drivers did not (11/57 in LVZ, 19.3%; p<0.001). The proportion of the left atrium (LA) occupied by LVZs predicted rotational driver occurrence (AUC 0.96, 95%CI 0.90-1.00; p<0.001). In patients with a relatively healthy atrium, where the atrium was made up of ≤15% LVZs, only focal drivers were identified. Eighteen of the 21 (85.7%) rotational drivers located in LVZs also showed a temporal and spatial relationship to a focal driver. The presence of a LVZ within 12 mm of the focal driver was a strong predictor for whether a paired rotational driver would also occur in that vicinity.
Conclusions Rotational drivers are largely confined to areas of structural remodelling and have a clear spatial and temporal relationship with focal drivers suggesting they are dependent on them. These novel mechanistic observations outline a plausible model for patient specific mechanisms maintaining AF.
Competing Interest Statement
Dr Honarbakhsh is a British Heart Foundation Clinical Intermediate Fellow and receives a British Heart Foundation Fellowship Grant. Dr Honarbakhsh has received speaker?s fees from Abbott. Professor Hunter has received research grants, educational grants, and speaker?s fees from Biosense Webster, Medtronic and Abbott. Dr Honarbakhsh and Professor Hunter are shareholders in Rhythm AI Ltd. Dr Roney acknowledges a UKRI Future Leaders Fellowship (MR/W004720/1).
Funding Statement
British Heart Foundation Clinical Intermediate Fellowship FS/ICRF/22/26034
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Patients provided informed consent for their study involvement which was approved by the UK National Research Ethics Service (22/PR/0961).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵Disclosures: Dr Honarbakhsh is a British Heart Foundation Clinical Intermediate Fellow and receives a British Heart Foundation Fellowship Grant. Dr Honarbakhsh has received speaker’s fees from Abbott. Professor Hunter has received research grants, educational grants, and speaker’s fees from Biosense Webster, Medtronic and Abbott. Dr Honarbakhsh and Professor Hunter are shareholders in Rhythm AI Ltd. Dr Roney acknowledges a UKRI Future Leaders Fellowship (MR/W004720/1).
↵Funding: British Heart Foundation Clinical Intermediate Fellowship FS/ICRF/22/26034
Data Availability
The data underlying this article will be shared on reasonable request to the corresponding author.
